Leading Japanese law firm Nishimura & Asahi has advised Kyowa Hakko Kirin Co., Ltd. on its transfer of 66.6% shares of Kyowa Medex Co., Ltd., which operates research, development, manufacturing and sales business of in-vitro diagnostics and automated analyzers, to Hitachi Chemical Co., Ltd.

The Nishimura & Asahi team advising Kyowa Hakko Kirin was led by partner Yuki Oi.